Skip to search formSkip to main contentSkip to account menu

cipamfylline

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Background: Eczema is a very common chronic inflammatory skin condition. Objectives: To update the National Institute for Health… 
Review
2007
Review
2007
The phosphodiesterase (PDE) 4 is the predominant cyclic AMP degrading enzyme in a variety of inflammatory cells including… 
2003
2003
BackgroundNew therapeutic approaches have to be considered in the treatment of irritant contact dermatitis (ICD). Recently… 
Review
2003
Review
2003
Gateways to clinical trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2002
2002
Summary Background Therapeutic options to treat atopic dermatitis are limited. Leukocytes from atopic patients have an abnormally… 
2002
2002
2002
1998
1998
La presente invention concerne de nouvelles formes polymorphes cristallines, Forme I, II et IV de la Cipamfylline, leurs procedes… 
1998
1998
(57) [summary] The present invention relates to a novel crystalline polymorph form a is type I cipamfylline, II and IV type, a…